Protein Phosphatase 2A (PP2A)-specific Ubiquitin Ligase MID1 Is a Sequence-dependent Regulator of Translation Efficiency Controlling 3-Phosphoinositide-dependent Protein Kinase-1 (PDPK-1)-Reference-Cited by-同舟云学术

Protein Phosphatase 2A (PP2A)-specific Ubiquitin Ligase MID1 Is a Sequence-dependent Regulator of Translation Efficiency Controlling 3-Phosphoinositide-dependent Protein Kinase-1 (PDPK-1)

Published:2011-11 Issue:46 Volume:286 Page:39945-39957
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Aranda-Orgillés Beatriz,Rutschow Désirée,Zeller Raphael,Karagiannidis Antonios I.,Köhler Andrea,Chen Changwei,Wilson Timothy,Krause Sven,Roepcke Stefan,Lilley David,Schneider Rainer,Schweiger Susann

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference52 articles.

1. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22

2. Ig Receptor Binding Protein 1 (α4) Is Associated With a Rapamycin-Sensitive Signal Transduction in Lymphocytes Through Direct Binding to the Catalytic Subunit of Protein Phosphatase 2A

3. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation

4. TOR signalling in bugs, brain and brawn

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. It’s a TRIM-endous view from the top: the varied roles of TRIpartite Motif proteins in brain development and disease;Frontiers in Molecular Neuroscience;2023-12-05

2. Mid1 is associated with androgen-dependent axonal vulnerability of motor neurons in spinal and bulbar muscular atrophy;Cell Death & Disease;2022-07-13

3. TRIM-NHL as RNA Binding Ubiquitin E3 Ligase (RBUL): Implication in development and disease pathogenesis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2021-07

4. The MID1 gene product in physiology and disease;Gene;2020-07

5. AR-dependent phosphorylation and phospho-proteome targets in prostate cancer;Endocrine-Related Cancer;2020-06